KCG
JAZZ icon

Knight Capital Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Knight Capital Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$290K Buy
+4,224
New +$258K 0.01% 2277

Other funds holding JAZZ

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return

Knight Capital Group's JAZZ Position: Q2 2013 in Review

Knight Capital Group opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2013: 4,224 shares worth $290K. The stake represents 0.01% of the portfolio and ranks #2277 among its holdings.

234 funds tracked by Wall St. Rank hold JAZZ as of Q2 2013.

  • Knight Capital Group held 4,224 shares of Jazz Pharmaceuticals worth $290K as of Q2 2013.
  • Jazz Pharmaceuticals was a new Knight Capital Group position in Q2 2013.
  • Jazz Pharmaceuticals made up 0.01% of Knight Capital Group's portfolio in Q2 2013, its #2277 holding.
  • 234 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.